1 not yet recruiting, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Unknown 1 |
Follow Diabetic Chronic Kidney Disease: new trials by email Literature Review of Diabetic Chronic Kidney Disease trials Research Report on Diabetic Chronic Kidney Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Precision T1D Platform - New Therapies for Cardio-Renal Complications Finerenone, Sotagliflozin - Type 1 Diabetes, T1D Heart Failure | Phase 2 | Not yet recruiting | Oregon Health and Science University | 57 | 2026-11-01 | 2026-08-10 |
| A Phase 2b Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes GCS-100, Placebo - Diabetic Chronic Kidney Disease | Phase 2 | Unknown | La Jolla Pharmaceutical Company | 375 | 2015-03-01 | 2015-05-19 |
Diabetes Mellitus, Type 1 (1) · Heart Failure (1)
Autoimmune Diseases (1) · Cardiovascular Diseases (1) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Heart Diseases (1) · Immune System Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol (1) · GCS-100 (1) · finerenone (1)
La Jolla Pharmaceutical Company (1) · Oregon Health and Science University (1)
United States (2)